- Home
- AQN vs APGE Comparison
AQN vs APGE Comparison
Compare AQN & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AQN | APGE |
|---|---|---|
| Founded | 1988 | 2022 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.7B |
| IPO Year | 1998 | 2023 |
Fundamental Metrics
Financial Performance| Metric | AQN | APGE |
|---|---|---|
| Price | $6.42 | $78.60 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 9 |
| Target Price | $6.46 | ★ $101.89 |
| AVG Volume (30 Days) | ★ 4.6M | 1.0M |
| Earning Date | 11-07-2025 | 11-10-2025 |
| Dividend Yield | ★ 4.19% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,387,738,000.00 | N/A |
| Revenue This Year | $4.72 | N/A |
| Revenue Next Year | $3.99 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.90 | N/A |
| 52 Week Low | $4.19 | $26.20 |
| 52 Week High | $6.48 | $80.99 |
Technical Indicators
Market Signals| Indicator | AQN | APGE |
|---|---|---|
| Relative Strength Index (RSI) | 66.00 | 65.69 |
| Support Level | $6.04 | $72.56 |
| Resistance Level | $6.20 | $78.34 |
| Average True Range (ATR) | 0.14 | 3.38 |
| MACD | 0.01 | -0.51 |
| Stochastic Oscillator | 64.66 | 74.20 |
Price Performance
Historical ComparisonAbout AQN Algonquin Power & Utilities Corp.
Algonquin Power & Utilities Corp is a Canada-based diversified international generation, transmission, and distribution company. The company's operations are organized across two business units consisting of the Regulated Services Group, which owns and operates a portfolio of regulated electric, water distribution and wastewater collection, and natural gas utility systems and transmission operations in the United States, Canada, Bermuda, and Chile; and the Hydro Group, which consists of hydroelectric-generating facilities located in Canada. It generates the majority of its revenue from the Regulated Services Group segment.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.